RecruitingNot ApplicableNCT06654466

Closing the GAPS: Guideline Adherence, Prevention and Surveillance in Hereditary Cancer

Enhancing Information Management for Young Adults After Genetic Cancer Risk Testing


Sponsor

Nest Genomics

Enrollment

100 participants

Start Date

Feb 10, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this clinical trial is to see if a software platform can improve cancer screening in young adults with genetic risk for cancer. The trial will also help improve the software platform (Nest). The main questions it aims to answer are: * Do Nest users know more about their cancer risks and recommended care than non-users? * Do Nest users have less psychological distress than non-users? * Do Nest users share cancer risks with family and other doctors more than non-users? * Are Nest users more likely than non-users to have up-to-date care plans? Researchers will compare Nest users to non-users to see if the Nest users are more likely to do recommended cancer screening. Participants will: * Have a genetic counseling or follow up visit * Take a post-visit survey * Intervention arm only: use the Nest Patient Navigator * Complete screening and follow-up care recommended by doctors


Eligibility

Min Age: 18 YearsMax Age: 49 Years

Inclusion Criteria5

  • Ages 18-49 years, inclusive
  • previous cancer genetic testing with a finding of a pathogenic or likely pathogenic variant resulting in an increased risk of cancer warranting clinical management.
  • English-speaking and -reading
  • Receiving care at Dana Farber Cancer Institute
  • Not in active cancer therapy at the time of approach

Exclusion Criteria5

  • Age \<18 or \>49 years
  • Has not had genetic testing for hereditary cancer syndromes or has been tested but no pathogenic or likely pathogenic variant was identified.
  • Non-English speaking and reading
  • Not receiving care at Dana Farber Cancer Institute
  • Active cancer with therapy in progress

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICENest, an electronic medical record (EMR)-integrated software platform to deliver longitudinal, genetics-based care at scale.

The Nest software platform includes the Nest Care Studio, Nest Patient Navigator and the Analytics Dashboard. Nest Care Studio is a clinician facing portal that can be used standalone or electronic medical record (EMR) integrated. Care Studio enables clinicians to effectively manage patients' genetic information over time. Clinicians can see a list of patients that meet criteria for testing, run risk assessment calculations, order genetic tests, manage patients based on results and view education modules.The Nest Patient Navigator is a secure mobile device accessible platform that provides a centralized location for patients to store, manage, and follow-up with their genetic results. The Analytics Dashboard is an interactive dashboard that can track outcomes of genomic programs and trigger interventions to optimize them.


Locations(1)

Dana Farber Cancer Institute

Boston, Massachusetts, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06654466


Related Trials